Cómo la imagenología está transformando el manejo de enfermedades metabólicas

• Autores: Juan Ángel Dalda Navarro, Enrique Negre Ferrer, Carlos Negre Ferrer, Ana Belén Navarro Martín, María Teresa Navarro Martín, Verónica Dalda Navarro
• Localización: Revista Sanitaria de Investigación, ISSN-e 2660-7085, Vol. 5, Nº. 7, 2024
• Idioma: español
• Enlaces
  • Texto completo
• Resumen
  • español

    La imagenología médica ha emergido como una herramienta esencial en el diagnóstico, monitoreo y tratamiento de enfermedades metabólicas. Tecnologías avanzadas como la resonancia magnética (RM), la tomografía por emisión de positrones (PET) y la tomografía computarizada (TC) están permitiendo una comprensión más profunda de estas enfermedades, facilitando una intervención más temprana y precisa. Este artículo explora cómo estas tecnologías están transformando el manejo clínico de condiciones metabólicas como la diabetes, la enfermedad hepática grasa no alcohólica (NAFLD) y la osteoporosis.

  • English

    Medical imaging has emerged as an essential tool in the diagnosis, monitoring and treatment of metabolic diseases. Advanced technologies such as magnetic resonance imaging (MRI), positron emission tomography (PET) and computed tomography (CT) are enabling a deeper understanding of these diseases, facilitating earlier and more precise intervention. This article explores how these technologies are transforming the clinical management of metabolic conditions such as diabetes, non-alcoholic fatty liver disease (NAFLD), and osteoporosis.

• Referencias bibliográficas
  • Thomas EL, Parkinson JR, Frost GS, Goldstone AP, Dore CJ, McCarthy JP, et al. The application of imaging to nutritional clinical trials. Nutr...
  • Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride...
  • Therkelsen KE, Pedley A, Speliotes EK, Massaro JM, Murabito JM, Hoffmann U, et al. Intramuscular fat and associations with metabolic risk...
  • Rijzewijk LJ, van der Meer RW, Lamb HJ, de Jong HW, Lubberink M, Romijn JA, et al. Altered myocardial substrate metabolism and decreased myocardial...
  • McMahon SK, Williams AD, Frost L, Stevens MJ, Green AJ. Abnormalities of the metabolic syndrome in teenagers with type 1 diabetes and their...
  • Blake GM, Park-Holohan SJ, Cook GJ, Fogelman I. Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate....
  • Agten CA, Rosskopf AB, Zanetti M, Bhure U, Guglielmi G, Buck FM. CT Osteoporosis Score of the Proximal Femur: Correlation with DXA Measurements...
  • Yin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography....
  • Valk PE, Pounds TR, Tesar RD, Hopkins DM, Haseman MK, Greiss HB, et al. Cost-effectiveness of PET imaging in clinical oncology. Nucl Med Biol....
  • Genant HK, Engelke K, Fuerst T, Glüer CC, Grampp S, Harris ST, et al. Noninvasive assessment of bone mineral and structure: state of the art....
  • Adams LA, Feldstein A. Non-invasive diagnosis of nonalcoholic fatty liver and non-alcoholic steatohepatitis. J Dig Dis. 2011;12(1):10-6.
  • Goldstein LB. Potential effects of a primary stroke center on outcomes, costs, and utilization. Neurology. 2002;58(12):1673-7.
  • Rosenthal DI, Boland GW, Kattapuram SV. Imaging of metabolic bone disease. Radiology. 1989;172(2):513-24.
  • DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015; 1:15019.
  • Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn...
  • Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients...
  • Bredella MA, Gill CM, Gerweck AV, Landa MG, Kumar V, Daley SM, et al. Ectopic and serum lipid levels are positively associated with bone marrow...
  • Van der Graaf M. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. Eur Biophys J. 2010;39(4):527-40.
  • Gariani K, de Kalbermatten A, Philippe J, Jornayvaz FR. Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside. Diabetes...
  • Bashir MR, Hong CW, Reeder SB. Magnetic resonance imaging of hepatic steatosis: current and emerging methods. J Magn Reson Imaging. 2015;42(6):1497-512.